Stimulation by soluble CD70 promotes strong primary and secondary CD8+ cytotoxic T cell responses in vivo

被引:92
作者
Rowley, TF [1 ]
Al-Shamkhani, A [1 ]
机构
[1] Southampton Gen Hosp, Tenovus Res Lab, Canc Sci Div, Sch Med, Southampton SO16 6YD, Hants, England
关键词
D O I
10.4049/jimmunol.172.10.6039
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Identification of the signals required for optimal differentiation of naive CD8(+) T cells into effector and memory cells is critical for the design of effective vaccines. In this study we demonstrate that CD27 stimulation by soluble CD70 considerably enhances the magnitude and quality of the CD8(+) T cell response. Stimulation with soluble CD70 in the presence of Ag significantly enhanced the proliferation of CD8(+) T cells and their ability to produce IL-2 and IFN-gamma in vitro. Administration of Ag and soluble CD70 resulted in a massive (>300-fold) expansion of Ag-specific CD8(+) T cells in vivo, which was due to the enhanced proliferation and survival of activated T cells. In mice that received Ag and soluble CD70, CD8(+) T cells developed into effectors with direct ex vivo cytotoxicity. Furthermore, unlike peptide immunization, which resulted in a diminished response after rechallenge, CD27 stimulation during the primary challenge evoked a strong secondary response upon rechallenge with the antigenic peptide. Thus, in addition to increasing the frequency of primed Ag-specific T cells, CD27 signaling during the primary response instills a program of differentiation that allows CD8(+) T cells to overcome a state of unresponsiveness. Taken together these results demonstrate that soluble CD70 has potent in vivo adjuvant effects for CD8(+) T cell responses.
引用
收藏
页码:6039 / 6046
页数:8
相关论文
共 53 条
[31]   Spinning molecular immunology into successful immunotherapy [J].
Pardoll, DM .
NATURE REVIEWS IMMUNOLOGY, 2002, 2 (04) :227-238
[32]  
ROBERTS BR, 2000, DRUG DISCOVERY TOD S, V1, P10
[33]   Progress in human tumour immunology and immunotherapy [J].
Rosenberg, SA .
NATURE, 2001, 411 (6835) :380-384
[34]   Immature dendritic cells acquire CD8+ cytotoxic T lymphocyte priming capacity upon activation by T helper cell-independent or -dependent stimuli [J].
Schuurhuis, DH ;
Laban, S ;
Toes, REM ;
Ricciardi-Castagnoli, P ;
Kleijmeer, MJ ;
van der Voort, EIH ;
Rea, D ;
Offringa, R ;
Geuze, HJ ;
Melief, CJM ;
Ossendorp, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (01) :145-150
[35]   T cell anergy [J].
Schwartz, RH .
ANNUAL REVIEW OF IMMUNOLOGY, 2003, 21 :305-334
[36]   The B7-CD28 superfamily [J].
Sharpe, AH ;
Freeman, GJ .
NATURE REVIEWS IMMUNOLOGY, 2002, 2 (02) :116-126
[37]   Requirement for CD4 T cell help in generating functional CD8 T cell memory [J].
Shedlock, DJ ;
Shen, H .
SCIENCE, 2003, 300 (5617) :337-339
[38]  
SHIMONKEVITZ R, 1984, J IMMUNOL, V133, P2067
[39]   CTLA-4 blockade reverses CD8+ T cell tolerance to tumor by a CD4+ T cell-and IL-2-dependent mechanism [J].
Shrikant, P ;
Khoruts, A ;
Mescher, MF .
IMMUNITY, 1999, 11 (04) :483-493
[40]   Defective CD8 T cell memory following acute infection without CD4 T cell help [J].
Sun, JC ;
Bevan, MJ .
SCIENCE, 2003, 300 (5617) :339-342